![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
W Martin, RF Furchgott, GM Villani and D Jothianandan
The selective cyclic GMP phosphodiesterase inhibitor M&B 22948 and the less selective phosphodiesterase inhibitors papaverine and isobutylmethylxanthine (IBMX) each induced a component of relaxation of rat aortic rings that was endothelium-dependent. The most selective agent at inducing endothelium-dependent relaxation was M&B 22948, which caused little relaxation of endothelium-denuded rings at concentrations that produced almost complete relaxation of endothelium-containing rings. Although endothelium-dependent components of relaxation induced by papaverine and IBMX were clearly present, they were less well separated from the endothelium-independent components of relaxation. In the aorta of the rabbit, M&B 22948 and papaverine were less affective at inducing an endothelium-dependent component of relaxation than in the aorta of the rat, and IBMX produced no discernible endothelium- dependent component. The endothelium-dependent components of relaxation induced by M&B 22948, papaverine and IBMX on rat and rabbit aorta were probably dependent on endothelium-derived relaxing factor (EDRF), because they were associated with concomitant endothelium-dependent rises in cyclic GMP, and these components of relaxation as well as the rises in cyclic GMP were completely blocked by the EDRF-blocking agent hemoglobin. The action of hemoglobin was entirely specific, as none of the endothelium-independent components of relaxation induced by any of the phosphodiesterase inhibitors was affected by this hemoprotein. It is likely that the phosphodiesterase inhibitors induce their endothelium-dependent components of relaxation by inhibiting the hydrolysis of cyclic GMP formed in response to EDRF released spontaneously from endothelial cells.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. Kimura, Y. Higashi, K. Hara, K. Noma, S. Sasaki, K. Nakagawa, C. Goto, T. Oshima, M. Yoshizumi, and K. Chayama PDE5 Inhibitor Sildenafil Citrate Augments Endothelium-Dependent Vasodilation in Smokers Hypertension, May 1, 2003; 41(5): 1106 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. J. Halcox, K. R. A. Nour, G. Zalos, R. Mincemoyer, M. A. Waclawiw, C. E. Rivera, G. Willie, S. Ellahham, and A. A. Quyyumi The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, and S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J. Am. Coll. Cardiol., September 1, 2000; 36(3): 845 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Wallace and W. L. Tom Interaction of L-Arginine and Phosphodiesterase Inhibitors in Vasodilation of the Porcine Internal Mammary Artery Anesth. Analg., April 1, 2000; 90(4): 840 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujishige, J. Kotera, H. Michibata, K. Yuasa, S.-i. Takebayashi, K. Okumura, and K. Omori Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A) J. Biol. Chem., June 25, 1999; 274(26): 18438 - 18445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Rosenfeldt, G.-W. He, B. F. Buxton, and J. A. Angus Pharmacology of coronary artery bypass grafts Ann. Thorac. Surg., March 1, 1999; 67(3): 878 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kotera, K. Fujishige, H. Akatsuka, Y. Imai, N. Yanaka, and K. Omori Novel Alternative Splice Variants of cGMP-binding cGMP-specific Phosphodiesterase J. Biol. Chem., October 9, 1998; 273(41): 26982 - 26990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nishizawa, S. Yamamoto, T. Yokoyama, H. Ryu, and K. Uemura Chronological Changes of Arterial Diameter, cGMP, and Protein Kinase C in the Development of Vasospasm Stroke, October 1, 1995; 26(10): 1916 - 1921. [Abstract] [Full Text]
|
|
|
|
 |
|
 G.-W. He, B. F. Buxton, F. L. Rosenfeldt, J. A. Angus, and J. Tatoulis Pharmacologic dilatation of the internal mammary artery during coronary bypass grafting J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1440 - 1444. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
